Skip to main content
SpringerLink
Log in

Pharmaceutical industry financial performance

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Net present value (NPV) gap analysis for the large-cap pharmaceutical companies in 2009E–2015E.

Author information

Authors and Affiliations

  1. Michael Goodman is at AVOS Life Sciences, 1600 Perimeter Park Drive, Morrisville, North Carolina 27560, USA.,

    Michael Goodman

Authors
  1. Michael Goodman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Goodman.

Supplementary information

Supplementary information S1 (box)

Basis of analysis (PDF 196 kb)

Supplementary information S2 (figure)

Distributions of sales compound annual growth rates by period. (PDF 210 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goodman, M. Pharmaceutical industry financial performance. Nat Rev Drug Discov 8, 927–928 (2009). https://doi.org/10.1038/nrd3049

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3049

  • Springer Nature Limited

This article is cited by

Search

Navigation